← FDA Drug Approvals (Drugs@FDA)

NIRAVAM

NDA · New Drug Application · Sponsor: UCB INC · Approved 2005-01-19

Drug application

FDA Application #

NDA021726

Application type

New Drug Application

Brand name

NIRAVAM

Generic name

Alprazolam

Active ingredients

ALPRAZOLAM

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Marketing status

Discontinued

Sponsor

UCB INC

First approval

2005-01-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown